Research and Markets: The Global Gene Therapy Industry Has the Potential to Become a Multi-Million Dollar Industry by the End of 2017 Says Latest Offering
DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/phl43h/global_gene) has announced the addition of the "Global Gene Therapy Market Analysis" report to their offering.
Gene therapy is the treatment of a disease by replacing, altering, or supplementing a gene that is absent or abnormal and whose absence or abnormality is causing the disease. It has evolved as one of the most sought after research objectives for difficult to cure' diseases. The gene therapy market in spite of presenting few marketable products and being nascent in terms of revenue generation holds tremendous growth potential. As per a new estimation carried out in our latest study, the global gene therapy industry has the potential to become a multi-million dollar industry by the end of 2017 as new products, especially those in the advanced stage of clinical studies or with pending approvals, may enter the market to boost the growth.
According to the new research report, Global Gene Therapy Market Analysis, major focus has been made on the ongoing clinical trials for the development of innovative products. Majority trials are focused on oncology and they prove promising on global scale for US. In this context, the study provides a comprehensive overview of the various aspects of clinical trials in the gene therapy market such as phases, geographies, vector types etc.
The report provides an in-depth and prudent analysis of the industry and research developments taking place at the global level. Primarily the market is presently dominated by oncology applications with several companies and academic institutions focusing on novel and difficult to treat' cancers. Other therapeutic areas seeing developments on gene therapy include cardiac conditions, genetic disorders and neurological diseases. An effective analysis of the key therapeutic areas has been included in the report.
- AnGes MG, Inc
- Ark Therapeutics
- Ceregene, Inc
- Cobra Biologics
- GenVec, Inc
- Genzyme Corporation
- Vical, Inc
- Oxford BioMedica
For more information visit http://www.researchandmarkets.com/research/phl43h/global_gene
About Research and Markets
Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.